Effect of lidocaine cream analgesia for chest drain tube removal after video-assisted thoracoscopic surgery for lung cancer: a randomized clinical trial.

acute pain pain measurement postoperative pain

Journal

Regional anesthesia and pain medicine
ISSN: 1532-8651
Titre abrégé: Reg Anesth Pain Med
Pays: England
ID NLM: 9804508

Informations de publication

Date de publication:
20 Nov 2019
Historique:
received: 05 06 2019
revised: 30 10 2019
accepted: 06 11 2019
entrez: 22 11 2019
pubmed: 22 11 2019
medline: 22 11 2019
Statut: aheadofprint

Résumé

Pain management makes an important contribution to good respiratory care and early recovery after thoracic surgery. Although the development of video-assisted thoracoscopic surgery (VATS) has led to improved patient outcomes, chest tube removal could be distressful experience for many patients. The aim of this trial was to test whether the addition of lidocaine cream would have a significant impact on the pain treatment during chest tube removal from patients who had undergone VATS for lung cancer. This clinical trial was a double-blind randomized study. Forty patients with histologically confirmed lung cancer amenable to lobectomy/segmentectomy were enrolled. All patients had standard perioperative care. Patients were randomly assigned to receive either epidural anesthesia plus placebo cream (placebo, Group P) or epidural anesthesia plus 7% lidocaine cream cutaneously around the chest tube insertion site and on the skin over the tube's course 20 min (Group L) before chest drain removal. Visual analog scale (VAS) scores were higher in Group P (median 5, IQR, 3.25-8) than in Group L (median 2, IQR, 1-3). Pain intensities measured using a PainVision system were also higher in Group P (median 296.7, IQR, 216.9-563.5) than Group L (median 41.2, IQR, 11.8-97.0). VAS scores and the pain intensity associated with chest drain removal were significantly lower in Group L than Group P (p=0.0002 vs p<0.0001). Analgesia using lidocaine cream is a very simple way to reduce the pain of chest tube removal after VATS. UMIN000013824.

Sections du résumé

BACKGROUND AND OBJECTIVES OBJECTIVE
Pain management makes an important contribution to good respiratory care and early recovery after thoracic surgery. Although the development of video-assisted thoracoscopic surgery (VATS) has led to improved patient outcomes, chest tube removal could be distressful experience for many patients. The aim of this trial was to test whether the addition of lidocaine cream would have a significant impact on the pain treatment during chest tube removal from patients who had undergone VATS for lung cancer.
METHODS METHODS
This clinical trial was a double-blind randomized study. Forty patients with histologically confirmed lung cancer amenable to lobectomy/segmentectomy were enrolled. All patients had standard perioperative care. Patients were randomly assigned to receive either epidural anesthesia plus placebo cream (placebo, Group P) or epidural anesthesia plus 7% lidocaine cream cutaneously around the chest tube insertion site and on the skin over the tube's course 20 min (Group L) before chest drain removal.
RESULTS RESULTS
Visual analog scale (VAS) scores were higher in Group P (median 5, IQR, 3.25-8) than in Group L (median 2, IQR, 1-3). Pain intensities measured using a PainVision system were also higher in Group P (median 296.7, IQR, 216.9-563.5) than Group L (median 41.2, IQR, 11.8-97.0). VAS scores and the pain intensity associated with chest drain removal were significantly lower in Group L than Group P (p=0.0002 vs p<0.0001).
CONCLUSION CONCLUSIONS
Analgesia using lidocaine cream is a very simple way to reduce the pain of chest tube removal after VATS.
TRIAL REGISTRATION NUMBER BACKGROUND
UMIN000013824.

Identifiants

pubmed: 31748424
pii: rapm-2019-100760
doi: 10.1136/rapm-2019-100760
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© American Society of Regional Anesthesia & Pain Medicine 2019. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Shin-Nosuke Watanabe (SN)

Thoracic Surgery, Akita University Graduate School of Medicine School of Medicine, Akita, Japan.

Kazuhiro Imai (K)

Thoracic Surgery, Akita University Graduate School of Medicine School of Medicine, Akita, Japan i-karo@mui.biglobe.ne.jp.

Tetsu Kimura (T)

Anesthesia and Intensive Care Medicine, Akita University Graduate School of Medicine School of Medicine, Akita, Japan.

Yoshitaro Saito (Y)

Thoracic Surgery, Akita University Graduate School of Medicine School of Medicine, Akita, Japan.

Shinogu Takashima (S)

Thoracic Surgery, Akita University Graduate School of Medicine School of Medicine, Akita, Japan.

Ikuo Matsuzaki (I)

Thoracic Surgery, Akita University Graduate School of Medicine School of Medicine, Akita, Japan.

Nobuyasu Kurihara (N)

Thoracic Surgery, Akita University Graduate School of Medicine School of Medicine, Akita, Japan.

Maiko Atari (M)

Thoracic Surgery, Akita University Graduate School of Medicine School of Medicine, Akita, Japan.

Tsubasa Matsuo (T)

Thoracic Surgery, Akita University Graduate School of Medicine School of Medicine, Akita, Japan.

Hidenobu Iwai (H)

Thoracic Surgery, Akita University Graduate School of Medicine School of Medicine, Akita, Japan.

Yusuke Sato (Y)

Thoracic Surgery, Akita University Graduate School of Medicine School of Medicine, Akita, Japan.

Satoru Motoyama (S)

Thoracic Surgery, Akita University Graduate School of Medicine School of Medicine, Akita, Japan.

Kyoko Nomura (K)

Public Health, Akita University Graduate School of Medicine School of Medicine, Akita, Japan.

Toshiaki Nishikawa (T)

Anesthesia and Intensive Care Medicine, Akita University Graduate School of Medicine School of Medicine, Akita, Japan.

Yoshihiro Minamiya (Y)

Thoracic Surgery, Akita University Graduate School of Medicine School of Medicine, Akita, Japan.

Classifications MeSH